UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of March 2017
Commission File Number: 001-36073
ENZYMOTEC LTD.
(Translation of registrant’s name into English)
Sagi 2000 Industrial Area
P.O. Box 6
Migdal Ha’Emeq 2310001, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __
CONTENTS
On March 9, 2017, Enzymotec Ltd. (NASDAQ: ENZY) (the “Company”) announced the appointment of Erez Israeli as the Company’s President and Chief Executive Officer, effective April 18, 2017. A copy of the press release announcing the appointment is furnished as Exhibit 99.1 to this Form 6-K and is incorporated herein by reference.
The information in Exhibit 99.1 to this Form 6-K shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | ENZYMOTEC LTD. | |
| | | |
| Dated: March 9, 2017 | By: /s/ Oren Bryan | |
| | Name: Oren Bryan | |
| | Title: Chief Financial Officer | |
EXHIBIT INDEX
The following exhibit is furnished as part of this Form 6-K:
| Exhibit | | Description | |
| 99.1 | | Press release dated March 9, 2017 announcing the appointment of Erez Israeli as President and Chief Executive officer of Enzymotec Ltd. |
